Guide · 7 min · 2026-07-23
On-prem vs private cloud for Indian export plants
A buyer checklist for data residency and deployment choice when Indian pharmaceutical plants serve export customers—without forcing a public SaaS-only model.
Residency is a business decision
Export customers and corporate IT often care where regulated records live. Clarify whether the system must run on plant infrastructure, in your private cloud, or only as vendor-hosted SaaS.
Offline and air-gapped realities
Some sites need license activation and operations that survive constrained connectivity. Ask vendors to show the path—not a slide promising “cloud first” only.
Same validation story as you grow
Adding a plant should not invent a second architecture. Prefer one platform model with clear instance boundaries as you expand.
AI inside the perimeter
If assistants summarize documents or support investigations, ask where they run and whether your content trains vendor models. On-prem capable assistants matter for many GxP buyers.
Novaqis posture
Deploy on-premises or in your private cloud with data residency under your control. See India pharma, Southeast Asia, Middle East, and the earlier on-prem vs cloud guide for related reading.
Ready to see Novaqis on your terms?
We prefer live walkthroughs over generic slides. Ask for a demo or a tailored quote—no published list prices.